| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |